If eligible, your copay may drop to as low as $25/month, with a cap of $150 in monthly savings
Q3 2024: Novo Nordisk to acquire Cardior Pharmaceuticals for up to 1.025 billion to expand cardiometabolic pipeline Novo Nordisk announced the acquisition of Cardior Pharmaceuticals, a German biotech focused on RNA-based therapies for heart disease, to strengthen its cardiometabolic portfolio, including GLP-1-based treatments
This gradual approach helps minimize side effects while maximizing results
We view GLP-1s as metabolic training wheels. While the medication quiets the hunger signals, our team works with you to remodel your habits, stabilize your gut microbiome, and reset your insulin sensitivity
If you have a blood glucose meter, check your levels immediately
These are stubborn because the underlying tissue has adapted to a damaged state, and turning that around takes more time